Test: Avian paramyxovirus -1 (Newcastle disease virus)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)   Test method

WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.3.14 (Version adopted in May 2021)

b)   Test type

Qualitative

c)    Sample type

Swabs: Cloacal and oropharyngeal

Tissues: Brain, trachea, heart, lung, spleen, liver, intestine and kidney

d)   Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of  tissues/organs

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines section “Sending a sample’’

f)    TAT

7 - 14 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Influenza A virus (All avian Influenza strains including H5, H7 & H9)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)   Test method

WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.3.4 (Version adopted in May 2021)

b)   Test type

Qualitative

c)    Sample type

Swabs: Cloacal and oropharyngeal

Tissues: Brain, trachea, heart, lung, spleen, liver, intestine and kidney

d)   Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of  tissues/organs

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines section “Sending a sample’’

f)    TAT

7 - 14 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Equine Influenza virus (EI)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)   Test method

WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.7 (Version adopted in May 2019)

b)   Test type

Qualitative

c)    Sample type

Swab: Nasal

Transtracheal lavage

d)   Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Transtracheal lavage - 10 ml

e)   Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines section “Sending a sample’’

f)    TAT

7 - 14 working days

g)   Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)   Measurement of Uncertainty (MU)

N/A

i)     Expression of result

Virus isolated or no virus isolated

Test: Equine Viral Arteritis (EVA) – VNT

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)        Test method

WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.10 (Version adopted in May 2013)

b)        Test type

 Serum

c)         Sample type

Quantitative

d)        Sample Volume/Amount

5 - 7 ml

e)        Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines section “Sending a sample’’

f)         TAT

5 - 14 working days

g)        Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Negative or Positive (positive serum is reported in titers)

j)         Cut off titers

Negative:  A titer < 1:4 is considered negative

Positive: A titer of 1:4 or greater is considered positive

Dubious: A titer of 1:2 is considered dubious

Test: Equine Piroplasmosis (Babesia caballi + Theileria equi) - Indirect fluorescent antibody test (IFAT)

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)        Test method

WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.8 (Version adopted in May 2021)

b)        Test type

 Serum

c)         Sample type

Quantitative

d)        Sample Volume/Amount

5 - 7 ml

e)        Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines section “Sending a sample’’

f)         TAT

4 - 5 working days

g)        Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Negative, Positive (positive serum is reported in titers) or dubious

j)          Cut off titers

Negative:  A titer <1:80 is considered negative

Positive: A titer of 1:80+++ or greater is considered positive

Dubious:  A titer of 1:80+ or 1:80++

Test: MERS-Coronavirus (MERS - CoV) Isolation

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)        Test method

WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.5.2 (Version adopted in May 2021)

b)        Test type

Qualitative

c)         Sample type

Swab: Nasal

Tissues:  Lung and trachea

d)        Sample Volume/Amount

Swabs must be send in viral transport medium which can be collected from CVRL. Appropriate amount of  tissues/organs

e)        Sample submission

CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines section “Sending a sample’’

f)         TAT

7 - 14 working days

g)        Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Virus isolated or no virus isolated

Test: Fluorescent Antibody Virus Neutralization (FAVN) Test for Rabies

Accreditation status

ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024

Test specifications

 

a)        Test method

SOP CVRL VR 017 [WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, online 12th ed. 2023, Chapter 3.1.18 (May 2023 version)]

b)        Test type

Quantitative

c)         Sample type

Serum

d)        Sample Volume/Amount

1 - 2 ml

e)        Sample submission

CVRL does not conduct site visiting and sampling. Refer 'Rabies Antibody Test' for sending samples

f)         TAT

Within three weeks

g)        Results

Refer ‘CVRL- Guidelines’,  section “Results’’

h)        Measurement of Uncertainty (MU)

N/A

i)          Expression of result

Test titer is reported in International Units (IU)/ ml

j)       Note

As per WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, a test titer of 0.5 IU/ml or above indicates that the animal has an acceptable rabies antibody level.

 

© 2018 CVRL | Powered by whyIT Solutions